Adaptimmune Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADAP and other ETFs, options, and stocks.

About ADAP

Adaptimmune Therapeutics Plc is commercial-stage cell therapy company, which focuses on providing novel cell therapies to people with cancer. Its clinical pipeline includes Afami-cel, Lete-cel, and ADP-A2M4CD8.

CEO

Adrian Rawcliffe

CEOAdrian Rawcliffe

Employees

506

Employees506

Headquarters

Abingdon, Oxfordshire

HeadquartersAbingdon, Oxfordshire

Founded

2014

Founded2014

Employees

506

Employees506

ADAP Key Statistics

Market cap

71.68M

Market cap71.68M

Price-Earnings ratio

-1.01

Price-Earnings ratio-1.01

Dividend yield

—

Dividend yield—

Average volume

437.41K

Average volume437.41K

High today

$0.2864

High today$0.2864

Low today

$0.2681

Low today$0.2681

Open price

$0.27

Open price$0.27

Volume

616.45K

Volume616.45K

52 Week high

$1.48

52 Week high$1.48

52 Week low

$0.1951

52 Week low$0.1951

ADAP News

TipRanks 1d

Adaptimmune Settles Litigation with M.D. Anderson Cancer Center

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

50%

of 8 ratings

Buy

37.5%

Hold

50%

Sell

12.5%